CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.71
-0.06 (-2.17%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CCLD trades at premium valuation expecting 27.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CCLD trades at premium valuation expecting 27.0% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.71, which is considered oversold relative to its 30-day fair value range of $2.85 to $3.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.5) compared to its historical average (10.0). At these levels, the market is pricing in 27.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, CCLD is in a downtrend. The price is currently testing key support at $2.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CCLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.31 (+127.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CCLD is in a downtrend. The price is currently testing key support at $2.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CCLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.31 (+127.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.85 -
$3.05
Company Quality Score
47/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
55.8%
Protect Your Profits
Holding CCLD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 127.9% below Wall St target ($6.31)
- BEARISH: Market expects 27.0% growth - appears too optimistic based on history
- CAUTION: 5-day price weakness (-6.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$2.85 -
$3.05
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.35
(12.7%)
Support & Resistance Levels
Support Level
$2.67
Resistance Level
$3.08
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
20.52
Wall Street Target
$6.31
(+127.9%)
Revenue Growth (YoY)
8.8%
Profit Margin
9.8%
Valuation Premium vs History
+27.0% premium
PE vs Historical
20.5 vs 10.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+27.0%
(market-implied from PE analysis)
1-Year Target
$3.52
(+27%)
2-Year Target
$4.47
(+61%)
3-Year Target
$5.67
(+105%)
3-Yr Target (if PE normalizes)
(PE: 21→10)
PE COMPRESSION
$2.77
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -56.9%)
$2.19
(+-21%)
Base:
(SPY PE: 20.5, Growth: -56.9%)
$2.02
(-27%)
Bear:
(PE: 10.0, Growth: -56.9%)
$0.98
(-65%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 41.00 | Current EPS (TTM): $0.07
Bull Case
$6.09
(+125%)
Analyst growth 92.9%, PE expands to 45.1
Base Case
$5.54
(+104%)
Market implied 92.9%, PE stable at 41.0
Bear Case
$1.95
(-28%)
Severe decline -20.0%, PE contracts to 34.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 10:53 PM ET
Data refreshes hourly during market hours. Next update: 11:53 PM
Data refreshes hourly during market hours. Next update: 11:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
CCLD is a key holding in these high-performance investment strategies.
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced CCLD Option Strategies
Professional options setups generated by AI based on today's CCLD price and gamma walls.
